glp-1 companies Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Novo cuts GLP-1 prices 70%,
Description
Kennedy A, Frank RN
In our new model, weve taken a more aggressive stance with a normalized price erosion assumption of 7% annually
Liang, Y., Dor, V., Rowe, C
doi: 10.1038/s41598-023-34070-6
Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents
It's also the perfect time to track your cravings and feelings of fullness , so you can see your progress and adjust your eating habits mindfully
